Your browser doesn't support javascript.
loading
Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice.
Cathomas, Richard; Schardt, Julian; Pless, Miklos; Llado, Anna; Mach, Nicolas; Riklin, Christian; Haefeli, Jenny; Fear, Simon; Stenner, Frank.
Affiliation
  • Cathomas R; Department of Internal Medicine, Department of Oncology and Haematology, Kantonsspital Graubünden, Chur, Switzerland.
  • Schardt J; University Hospital for Medical Oncology, Inselspital Bern, Switzerland.
  • Pless M; Department of Medical Oncology, Kantonsspital Winterthur, Switzerland.
  • Llado A; Istitut Oncologico della Svizzera Italiana, Bellinzona, Switzerland.
  • Mach N; Hôpitaux Universitaires Genève, Geneva, Switzerland.
  • Riklin C; Department of Medical Oncology, Luzerner Kantonsspital, Luzern, Switzerland.
  • Haefeli J; Roche (Schweiz) AG, Reinach, Switzerland.
  • Fear S; F Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Stenner F; Universitätsspital Basel, Basel, Switzerland.
Swiss Med Wkly ; 150: w20223, 2020 May 04.
Article in En | MEDLINE | ID: mdl-32399958
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Limits: Humans Country/Region as subject: Europa Language: En Journal: Swiss Med Wkly Journal subject: MEDICINA Year: 2020 Document type: Article Affiliation country: Switzerland Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Limits: Humans Country/Region as subject: Europa Language: En Journal: Swiss Med Wkly Journal subject: MEDICINA Year: 2020 Document type: Article Affiliation country: Switzerland Country of publication: Switzerland